These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 31405866)
21. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae. Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G Am J Trop Med Hyg; 2006 Jun; 74(6):960-4. PubMed ID: 16760504 [TBL] [Abstract][Full Text] [Related]
22. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight. Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009 [TBL] [Abstract][Full Text] [Related]
23. Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial. Lingani M; Zango SH; Valéa I; Samadoulougou S; Somé G; Sanou M; Kaboré B; Rouamba T; Sorgho H; Tahita MC; Derra K; Dramaix M; Tinto H; Donnen P; Robert A Malar J; 2023 Mar; 22(1):101. PubMed ID: 36932435 [TBL] [Abstract][Full Text] [Related]
24. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin. Jafari-Guemouri S; Dhiab J; Massougbodji A; Deloron P; Tuikue NN Malar J; 2018 Oct; 17(1):356. PubMed ID: 30305101 [TBL] [Abstract][Full Text] [Related]
25. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial. Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921 [TBL] [Abstract][Full Text] [Related]
26. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241 [TBL] [Abstract][Full Text] [Related]
27. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Peters PJ; Thigpen MC; Parise ME; Newman RD Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875 [TBL] [Abstract][Full Text] [Related]
28. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi. Kapito-Tembo A; Meshnick SR; van Hensbroek MB; Phiri K; Fitzgerald M; Mwapasa V J Infect Dis; 2011 Feb; 203(4):464-72. PubMed ID: 21216867 [TBL] [Abstract][Full Text] [Related]
29. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial. Kajubi R; Ochieng T; Kakuru A; Jagannathan P; Nakalembe M; Ruel T; Opira B; Ochokoru H; Ategeka J; Nayebare P; Clark TD; Havlir DV; Kamya MR; Dorsey G Lancet; 2019 Apr; 393(10179):1428-1439. PubMed ID: 30910321 [TBL] [Abstract][Full Text] [Related]
30. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes. Valea I; Tinto H; Drabo MK; Huybregts L; Henry MC; Roberfroid D; Guiguemde RT; Kolsteren P; D'Alessandro U; Malar J; 2010 Nov; 9():324. PubMed ID: 24576068 [TBL] [Abstract][Full Text] [Related]
31. The effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trial. Luntamo M; Rantala AM; Meshnick SR; Cheung YB; Kulmala T; Maleta K; Ashorn P PLoS One; 2012; 7(7):e41123. PubMed ID: 22829919 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia. Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR Malar J; 2015 Feb; 14():69. PubMed ID: 25890159 [TBL] [Abstract][Full Text] [Related]
33. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700 [TBL] [Abstract][Full Text] [Related]
34. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia. Fryauff DJ; Sumawinata I; Purnomo ; Richie TL; Tjitra E; Bangs MJ; Kadir A; Ingkokusumo G Am J Trop Med Hyg; 1999 Apr; 60(4):542-6. PubMed ID: 10348226 [TBL] [Abstract][Full Text] [Related]
35. Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women. Moore BR; Benjamin JM; Auyeung SO; Salman S; Yadi G; Griffin S; Page-Sharp M; Batty KT; Siba PM; Mueller I; Rogerson SJ; Davis TM Br J Clin Pharmacol; 2016 Jul; 82(1):199-212. PubMed ID: 26889763 [TBL] [Abstract][Full Text] [Related]
36. Prevention and control of malaria in pregnancy - new threats, new opportunities? Rogerson SJ; Unger HW Expert Rev Anti Infect Ther; 2017 Apr; 15(4):361-375. PubMed ID: 27973923 [TBL] [Abstract][Full Text] [Related]